Logo-jcvtr

J Cardiovasc Thorac Res. 2022;14(2): 77-83. doi: 10.34172/jcvtr.2022.14
PMID: 35935390        PMCID: PMC9339732

Review Article

A glance at the application of CRISPR/Cas9 gene-editing technology in cardiovascular diseases

Neda Roshanravan 1 ORCID, Helda Tutunchi 2, Farzad Najafipour 2, Mohammadreza Dastouri 3 * ORCID, Samad Ghaffari 1 * ORCID, Alireza Jebeli 1

Cited by CrossRef: 1

1- Bonowicz K, Jerka D, Piekarska K, Olagbaju J, Stapleton L, Shobowale M, Bartosiński A, Łapot M, Bai Y, Gagat M. CRISPR-Cas9 in Cardiovascular Medicine: Unlocking New Potential for Treatment. Cells. 2025;14(2):131 [Crossref]
2- Alradwan I, AL Fayez N, Alomary M, Alshehri A, Aodah A, Almughem F, Alsulami K, Aldossary A, Alawad A, Tawfik Y, Tawfik E. Emerging Trends and Innovations in the Treatment and Diagnosis of Atherosclerosis and Cardiovascular Disease: A Comprehensive Review towards Healthier Aging. Pharmaceutics. 2024;16(8):1037 [Crossref]
3- Wal P, Aziz N, Singh C, Rasheed A, Tyagi L, Agrawal A, Wal A. Current Landscape of Gene Therapy for the Treatment of Cardiovascular Disorders. CGT. 2024;24(5):356 [Crossref]
4- Palaparthi E, Padala T, Singamaneni R, Manaswini R, Kantula A, Aditya Reddy P, Chandini P, Sathwika Eliana A, Siri Samhita P, Patnaik P. Emerging Therapeutic Strategies for Heart Failure: A Comprehensive Review of Novel Pharmacological and Molecular Targets. 2025; [Crossref]
5- Chen C, Sawamura T, Akhmedov A, Tsai M, Akyol O, Kakino A, Chiang H, Kraler S, Lüscher T. Evolving concepts of low‐density lipoprotein: From structure to function. Eur J Clin Investigation. 2025;55(5) [Crossref]
6- Moore O, Ho K, Copeland J, Parthasarathy V, Wehrens X. Genome Editing and Cardiac Arrhythmias. Cells. 2023;12(10):1363 [Crossref]